The Traderszone Network

Published in TZ Latest News 28 August, 2014 by The TZ Newswire Staff

Has Gilead Sciences, Inc.’s Star Drug Already Peaked?

Prescriptions of Gilead Sciences’ hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

read more